Discontinued — last reported Q4 '25
Product sales — Total revenues
Products & Services · Total revenuesAmgen Product sales — Total revenues remained flat by 0.0% to $8.79B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 9.7%, from $8.01B to $8.79B. Over 3 years (FY 2021 to FY 2025), Product sales — Total revenues shows an upward trend with a 13.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates growing market adoption or successful pricing strategies for the segment's products, while a decrease suggests potential market saturation, competitive pressure, or product lifecycle decline.
Detailed definition
This metric represents the total gross revenue generated from the sale of therapeutic products within a specific busines...
Peer comparison
Comparable to 'Net Product Sales' or 'Segment Revenue' reported by other large-cap biotechnology and pharmaceutical firms.
amgn_segment_product_sales_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.11B | $6.32B | $6.27B | $5.73B | $6.28B | $6.73B | $6.73B | $6.73B | $6.73B | $8.01B | $8.01B | $8.01B | $8.01B | $8.79B | $8.79B | $8.79B | $8.79B |
| QoQ Change | — | +3.4% | -0.8% | -8.6% | +9.6% | +7.1% | +0.0% | +0.0% | +0.0% | +19.0% | +0.0% | +0.0% | +0.0% | +9.7% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +2.7% | +17.4% | +7.1% | — | — | +19.0% | +19.0% | +19.0% | +19.0% | +9.7% | +9.7% | +9.7% | +9.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Amgen's product sales — total revenues?
- Amgen (AMGN) reported product sales — total revenues of $8.79B in Q4 2025.
- How has Amgen's product sales — total revenues changed year-over-year?
- Amgen's product sales — total revenues increased by 9.7% year-over-year, from $8.01B to $8.79B.
- What is the long-term trend for Amgen's product sales — total revenues?
- Over 3 years (2021 to 2025), Amgen's product sales — total revenues has grown at a 13.1% compound annual growth rate (CAGR), from $24.30B to $35.15B.
- What does product sales — total revenues mean?
- The total amount of money generated from selling products within this specific business segment.